PortfoliosLab logoPortfoliosLab logo
RIGL vs. TIGR
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

RIGL vs. TIGR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Rigel Pharmaceuticals, Inc. (RIGL) and UP Fintech Holding Limited (TIGR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, RIGL achieves a -29.77% return, which is significantly higher than TIGR's -51.15% return.


RIGL

1D
0.50%
1M
15.51%
YTD
-29.77%
6M
-30.69%
1Y
39.97%
3Y*
23.16%
5Y*
-5.96%
10Y*
2.33%

TIGR

1D
4.24%
1M
-27.71%
YTD
-51.15%
6M
-49.84%
1Y
-44.67%
3Y*
13.55%
5Y*
-29.56%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

RIGL vs. TIGR - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
RIGL
Rigel Pharmaceuticals, Inc.
-29.77%154.64%16.00%-3.33%-43.40%-24.29%63.55%-16.73%
TIGR
UP Fintech Holding Limited
-51.15%47.99%46.15%29.62%-30.55%-38.16%123.66%-67.49%

Correlation

The correlation between RIGL and TIGR is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (5Y)
Calculated over the trailing 5-year period

0.24

Correlation (All Time)
Calculated using the full available price history since Mar 21, 2019

0.24

The correlation between RIGL and TIGR shifts across timeframes, from 0.13 (1 year) to 0.24 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

RIGL:

$592.15M

TIGR:

$831.15M

EPS

RIGL:

$19.21

TIGR:

$0.62

PE Ratio

RIGL:

1.57

TIGR:

7.59

PEG Ratio

RIGL:

0.00

TIGR:

0.09

PS Ratio

RIGL:

1.90

TIGR:

1.34

PB Ratio

RIGL:

1.48

TIGR:

0.99

Total Revenue (TTM)

RIGL:

$299.77M

TIGR:

$645.56M

Gross Profit (TTM)

RIGL:

$279.95M

TIGR:

$533.82M

EBITDA (TTM)

RIGL:

$125.80M

TIGR:

$236.90M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

RIGL vs. TIGR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RIGL
RIGL Risk / Return Rank: 6161
Overall Rank
RIGL Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
RIGL Sortino Ratio Rank: 6464
Sortino Ratio Rank
RIGL Omega Ratio Rank: 6363
Omega Ratio Rank
RIGL Calmar Ratio Rank: 6060
Calmar Ratio Rank
RIGL Martin Ratio Rank: 5757
Martin Ratio Rank

TIGR
TIGR Risk / Return Rank: 1414
Overall Rank
TIGR Sharpe Ratio Rank: 1313
Sharpe Ratio Rank
TIGR Sortino Ratio Rank: 1515
Sortino Ratio Rank
TIGR Omega Ratio Rank: 1616
Omega Ratio Rank
TIGR Calmar Ratio Rank: 1717
Calmar Ratio Rank
TIGR Martin Ratio Rank: 1010
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RIGL vs. TIGR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Rigel Pharmaceuticals, Inc. (RIGL) and UP Fintech Holding Limited (TIGR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


RIGLTIGRDifference
Sharpe ratioReturn per unit of total volatility

+1.24

Sortino ratioReturn per unit of downside risk

+2.16

Omega ratioGain probability vs. loss probability

1.17

0.91

+0.26

Calmar ratioReturn relative to maximum drawdown

0.80

-0.67

+1.48

Martin ratioReturn relative to average drawdown

1.41

-1.35

+2.77

RIGL vs. TIGR - Sharpe Ratio Comparison

The current RIGL Sharpe Ratio is 0.58, which is higher than the TIGR Sharpe Ratio of -0.67. The chart below compares the historical Sharpe Ratios of RIGL and TIGR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


RIGLTIGRDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.58

-0.67

+1.24

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.07

-0.36

+0.29

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.03

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.13

-0.12

0.00

Drawdowns

RIGL vs. TIGR - Drawdown Comparison

The maximum RIGL drawdown since its inception was -99.37%, which is greater than TIGR's maximum drawdown of -93.65%. Use the drawdown chart below to compare losses from any high point for RIGL and TIGR.


Loading charts...

Drawdown Indicators


RIGLTIGRDifference

Max Drawdown

Largest peak-to-trough decline

-99.37%

-93.65%

-5.72%

Max Drawdown (1Y)

Largest decline over 1 year

-50.08%

-66.44%

+16.36%

Max Drawdown (3Y)

Largest decline over 3 years

-57.75%

-66.44%

+8.69%

Max Drawdown (5Y)

Largest decline over 5 years

-85.24%

-92.04%

+6.80%

Max Drawdown (10Y)

Largest decline over 10 years

-86.40%

Current Drawdown

Current decline from peak

-97.18%

-87.28%

-9.90%

Average Drawdown

Average peak-to-trough decline

-90.92%

-77.94%

-12.98%

Ulcer Index

Depth and duration of drawdowns from previous peaks

28.34%

33.03%

-4.69%

Volatility

RIGL vs. TIGR - Volatility Comparison

The current volatility for Rigel Pharmaceuticals, Inc. (RIGL) is 18.26%, while UP Fintech Holding Limited (TIGR) has a volatility of 35.71%. This indicates that RIGL experiences smaller price fluctuations and is considered to be less risky than TIGR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


RIGLTIGRDifference

Volatility (1M)

Calculated over the trailing 1-month period

18.26%

35.71%

-17.45%

Volatility (6M)

Calculated over the trailing 6-month period

38.39%

48.46%

-10.07%

Volatility (1Y)

Calculated over the trailing 1-year period

69.94%

67.34%

+2.60%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

85.50%

83.00%

+2.50%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

82.83%

89.75%

-6.92%

Dividends

RIGL vs. TIGR - Dividend Comparison

Neither RIGL nor TIGR has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

RIGL vs. TIGR - Financials Comparison

This section allows you to compare key financial metrics between Rigel Pharmaceuticals, Inc. and UP Fintech Holding Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M20222023202420252026
58.82M
155.34M
(RIGL) Total Revenue
(TIGR) Total Revenue
Values in USD except per share items

RIGL vs. TIGR - Profitability Comparison

The chart below illustrates the profitability comparison between Rigel Pharmaceuticals, Inc. and UP Fintech Holding Limited over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%90.0%100.0%20222023202420252026
92.2%
95.0%
Portfolio components
RIGL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a gross profit of 54.21M and revenue of 58.82M. Therefore, the gross margin over that period was 92.2%.

TIGR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, UP Fintech Holding Limited reported a gross profit of 147.59M and revenue of 155.34M. Therefore, the gross margin over that period was 95.0%.

RIGL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported an operating income of 11.89M and revenue of 58.82M, resulting in an operating margin of 20.2%.

TIGR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, UP Fintech Holding Limited reported an operating income of 65.89M and revenue of 155.34M, resulting in an operating margin of 42.4%.

RIGL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a net income of 8.65M and revenue of 58.82M, resulting in a net margin of 14.7%.

TIGR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, UP Fintech Holding Limited reported a net income of -26.92M and revenue of 155.34M, resulting in a net margin of -17.3%.


Frequently Asked Questions


RIGL and TIGR have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TIGR has higher volatility (35.71%) compared to RIGL (18.26%). In terms of maximum drawdown, RIGL dropped -99.37% vs TIGR's -93.65%.

RIGL currently has the higher Sharpe Ratio (0.58 vs -0.67), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for RIGL and TIGR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer